Announcements Trials
Browse Landscape

Phase

Phase NA 65Phase 2 21Phase 3 17Phase 1 6Phase 1/2 5Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 1

Status

Completed 6Terminated 5Recruiting 5Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Plasma cell 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Neoplasms 1331Breast Neoplasms 688Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 437Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 366Lymphoma, Non-Hodgkin 356Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 267Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 254Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Hodgkin Disease 193Carcinoma, Renal Cell 193Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Glioma 172Burkitt Lymphoma 172

Interventions

vistusertib 1ricolinostat 1pomalidomide 1irinotecan sucrosofate 1bermekimab 1TKM-080301 1Ipilimumab 1Fluorouracil 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Completed × Disease × Clear all
NCT04855929 2024-11-08

ANV419-001

Anaveon AG

Phase 1 Completed
55 enrolled
Thoracic

Disease, Lung Neoplasms, Neoplasms, Recurrence

NCT04904120 2023-11-07

TIMAR1

Perspective Therapeutics

Phase 1 Completed
7 enrolled
Dermatologic

Uveal Melanoma, Disease, Melanoma, Neoplasm Metastasis, Neoplasms

NCT03207724 2020-12-30

OnFX

Cedars-Sinai Medical Center

Phase 1 Completed
16 enrolled
Gastrointestinal

Adenocarcinoma, Cachexia, Disease, Pancreatic Neoplasms, Weight Loss

NCT02189343 2019-11-21

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Celgene

Phase 1 Completed
16 enrolled
Plasma cell

Disease, Multiple Myeloma, Recurrence, Disease Progression

NCT02064608 2019-07-17

CaNCaP02

Cambridge University Hospitals NHS Foundation Trust

Phase 1 Completed
23 enrolled
Genitourinary

Disease, Neoplasms, Prostatic Neoplasms

NCT01437007 2018-08-03

TKM 080301 for Primary or Secondary Liver Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
1 enrolled
BreastGastrointestinalGynecologic

Adenocarcinoma, Breast Neoplasms, Disease, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡